Source: Eur Respir J, 54 (3) 1900561; 10.1183/13993003.00561-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Christer Janson, Andrei Malinovschi, Andre F.S. Amaral, Simone Accordini, Jean Bousquet, A. Sonia Buist, Giorgio Walter Canonica, Barbro Dahlén, Judith Garcia-Aymerich, Louisa Gnatiuc, Marek L Kowalski, Jaymini Patel, Wan Tan, Kjell Torén, Torsten Zuberbier, Peter Burney, Deborah Jarvis. Bronchodilator reversibility in asthma and COPD: findings from three large population studies. Eur Respir J, 54 (3) 1900561; 10.1183/13993003.00561-2019

Member's Comments

No comment yet.

Related content which might interest you: Bronchodilator reversibility - differences between asthma and COPD Source: International Congress 2019 – Respiratory function assessment in disease Year: 2019 Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI Source: Virtual Congress 2020 – New imaging techniques applied to old problems Year: 2020 Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012 Baseline data and responses to oral steroid intervention in asthma and COPD: interim report from the BIOAIR EU study Source: Annual Congress 2007 - Asthma subphenotypes Year: 2007 Bronchodilator treatment for asthma and COPD Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010 Ventilation heterogeneity reversibility: asthma, COPD or ACOS? Source: International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses Year: 2017 The effects of early intervention with inhaled budesonide on lung function in mild persistent asthma: results from the START study Source: Eur Respir J 2003; 22: Suppl. 45, 34s Year: 2003 The clinical importance of small airway involvement in patients with asthma and COPD Source: International Congress 2019 – PG12 Recent advances in small airways diseases in patients with asthma and COPD Year: 2019 Prediction models for exacerbations in different COPD patient populations: Results of five large databases Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016 How the bronchodilatator in COPD patients works Source: Eur Respir J 2004; 24: Suppl. 48, 288s Year: 2004 Medication use in COPD: systematic review and meta-analysis Source: Annual Congress 2007 - Treatment and care of COPD Year: 2007 Characteristics of COPD patients with repeated exacerbations: preliminary results from the PRE-SPIRO survey Source: Annual Congress 2008 - COPD epidemiology Year: 2008 Omalizumab reduces asthma exacerbations and oral corticosteroid use in patients with severe allergic asthma: a systematic review of observational studies Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019 Preliminary results of relationship between appetite and clinical presentation of COPD patients in AERIS study Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Clinical phenotypes of asthmatics who require long-term use of tiotropium for asthma control: a real-world study Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019 Inhaled corticosteroids and FEV1 decline in asthma: an international cohort study Source: International Congress 2018 – Asthma in children and adults: long-term aspects Year: 2018 The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 A pilot study of CPAP therapy for excessive dynamic airway collapse during acute exacerbation of COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014